Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review

A Tufan, H LACHMANN - Turkish Journal of Medical …, 2020 - journals.tubitak.gov.tr
Abstract Familial Mediterranean fever (FMF)(OMIM# 249100) is the most common hereditary
autoinflammatory disease in the world. FMF is caused by gain of function mutations of MEFV …

Familial Mediterranean fever, review of the literature

M Alghamdi - Clinical rheumatology, 2017 - Springer
Familial Mediterranean fever (FMF) is the most common monogenic periodic fever syndrome
and characterized by recurrent episodes of fever, serositis, arthritis, dermal manifestations …

[HTML][HTML] Familial Mediterranean fever: an updated review

İ Sarı, M Birlik, T Kasifoğlu - European journal of rheumatology, 2014 - ncbi.nlm.nih.gov
Abstract Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disorder
characterised by acute attacks of fever and serosal inflammation. FMF primarily affects …

Familial mediterranean fever

H Ozdogan, S Ugurlu - La Presse Médicale, 2019 - Elsevier
Summary Familial Mediterranean Fever (FMF) is the oldest and the most frequent of all
described hereditary periodic fever syndromes. The populations originating from …

Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)

G El Hasbani, A Jawad, I Uthman - Orphanet journal of rare diseases, 2019 - Springer
Abstract Background Familial Mediterranean Fever (FMF), an autoinflammatory disease, is
characterized by self-limited inflammatory attacks of fever and polyserositis along with high …

Amyloidosis and glomerular diseases in familial Mediterranean fever

R Siligato, G Gembillo, V Calabrese, G Conti… - Medicina, 2021 - mdpi.com
Familial Mediterranean fever (FMF) is a genetic autoinflammatory disease with autosomal
recessive transmission, characterized by periodic fever attacks with self-limited serositis …

Predictors of persistent inflammation in familial Mediterranean fever and association with damage

H Babaoglu, B Armagan, E Bodakci, H Satis… - …, 2021 - academic.oup.com
Objective Persistent inflammation is an insidious and less studied feature of FMF. We
investigated clinical determinants of persistent inflammation and its associations with …

Efficacy of interleukin-1 targeting treatments in patients with familial Mediterranean fever

P Cetin, I Sari, B Sozeri, O Cam, M Birlik, N Akkoc… - Inflammation, 2015 - Springer
Herein, we reported our experience in colchicine-resistant familial Mediterranean fever
(FMF) patients who are treated with anti-interleukin-1 (IL-1) drugs. A retrospective review of …

Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever

S Ugurlu, A Hacioglu, Y Adibnia, V Hamuryudan… - Orphanet Journal of …, 2017 - Springer
Background There is no established treatment of AA amyloidosis, a long-term complication
of various chronic inflammatory diseases associated with increased mortality, such as …

The distribution of MEFV mutations in Turkish FMF patients: multicenter study representing results of Anatolia

NŞY Bilge, I Sari, D Solmaz, AS ŞENEL… - Turkish journal of …, 2019 - journals.tubitak.gov.tr
Background/aim: The distribution of Mediterranean fever (MEFV) gene mutations in Turkish
familial Mediterranean fever (FMF) patients varies according to geographic area of Turkey …